Literature DB >> 1756738

Mutation pattern of immunoglobulin transgenes is compatible with a model of somatic hypermutation in which targeting of the mutator is linked to the direction of DNA replication.

B Rogerson1, J Hackett, A Peters, D Haasch, U Storb.   

Abstract

We have previously demonstrated that B lymphocyte specific somatic mutations are introduced into the variable regions of immunoglobulin kappa transgenes in two independent transgenic mouse lines. The frequency, distribution and nature of these mutations strongly suggest that they arose as a result of the process of somatic hypermutation, which is responsible, in part, for affinity maturation during an immune response. Unexpectedly, in these multiple copy transgenic lines, many of the transgene copies showed no evidence of somatic mutation. This paradox was addressed by determining the sequence of each transgene copy in several B cell hybridomas derived from a mouse line carrying three copies of the kappa transgene. It was found that the somatic hypermutation process in different B cells from the same mouse preferentially targets one, but not the same, transgene copy. We present a model, based on the pattern of this targeting, which links somatic hypermutation to the orientation of the Ig gene relative to the direction of DNA replication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756738      PMCID: PMC453186          DOI: 10.1002/j.1460-2075.1991.tb05011.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  58 in total

1.  Boundaries of somatic mutation in rearranged immunoglobulin genes: 5' boundary is near the promoter, and 3' boundary is approximately 1 kb from V(D)J gene.

Authors:  S G Lebecque; P J Gearhart
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

2.  Exonucleolytic proofreading of leading and lagging strand DNA replication errors.

Authors:  J D Roberts; D C Thomas; T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Position of the rearranged V kappa and its 5' flanking sequences determines the location of somatic mutations in the J kappa locus.

Authors:  J S Weber; J Berry; T Manser; J L Claflin
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

4.  Antibody diversity: somatic hypermutation of rearranged VH genes.

Authors:  S Kim; M Davis; E Sinn; P Patten; L Hood
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

5.  Clusters of point mutations are found exclusively around rearranged antibody variable genes.

Authors:  P J Gearhart; D F Bogenhagen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

Review 6.  Gene conversion: some implications for immunoglobulin genes.

Authors:  D Baltimore
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

7.  Origin of antibody variation.

Authors:  S Brenner; C Milstein
Journal:  Nature       Date:  1966-07-16       Impact factor: 49.962

8.  Initiation of simian virus 40 DNA synthesis in vitro.

Authors:  P A Bullock; Y S Seo; J Hurwitz
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

9.  Somatic mutation in constant regions of mouse lambda 1 light chains.

Authors:  N Motoyama; H Okada; T Azuma
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

10.  Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes.

Authors:  M J Sharpe; C Milstein; J M Jarvis; M S Neuberger
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

View more
  19 in total

1.  Genomic targeting with a positive-selection lox integration vector allows highly reproducible gene expression in mammalian cells.

Authors:  S Fukushige; B Sauer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 2.  Molecular mechanism and function of CD40/CD40L engagement in the immune system.

Authors:  Raul Elgueta; Micah J Benson; Victor C de Vries; Anna Wasiuk; Yanxia Guo; Randolph J Noelle
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

3.  Cells strongly expressing Ig(kappa) transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers.

Authors:  B Goyenechea; N Klix; J Yélamos; G T Williams; A Riddell; M S Neuberger; C Milstein
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

4.  Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots.

Authors:  A G Betz; C Rada; R Pannell; C Milstein; M S Neuberger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

5.  An immunoglobulin mutator that targets G.C base pairs.

Authors:  J Bachl; M Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

6.  A well-differentiated B-cell line is permissive for somatic mutation of a transfected immunoglobulin heavy-chain gene.

Authors:  M Zhu; J L Rabinowitz; N S Green; B J Kobrin; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 7.  Cellular choreography in the germinal center: new visions from in vivo imaging.

Authors:  Anja E Hauser; Steven M Kerfoot; Ann M Haberman
Journal:  Semin Immunopathol       Date:  2010-07-09       Impact factor: 9.623

8.  Analysis of somatic hypermutation in mouse Peyer's patches using immunoglobulin kappa light-chain transgenes.

Authors:  A González-Fernández; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Immunoglobulin variable region hypermutation in hybrids derived from a pre-B- and a myeloma cell line.

Authors:  N S Green; J L Rabinowitz; M Zhu; B J Kobrin; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

10.  Comparison of somatic mutation frequency among immunoglobulin genes.

Authors:  N Motoyama; T Miwa; Y Suzuki; H Okada; T Azuma
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.